Journal article 567 views 61 downloads
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial
,
Hayley Hutchings ,
Alan Watkins ,
Shaji Sebastain,
John Williams
BMC Health Services Research, Volume: 23, Issue: 1
Swansea University Authors:
Samantha Groves, Laith Alrubaiy , Hayley Hutchings , Alan Watkins , John Williams
-
PDF | Version of Record
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder
Download (1.35MB)
DOI (Published version): 10.1186/s12913-023-09233-w
Abstract
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial
| Published in: | BMC Health Services Research |
|---|---|
| ISSN: | 1472-6963 |
| Published: |
Springer Science and Business Media LLC
2023
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa62906 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Funders: |
Open Access funding provided by the Qatar National Library. The CONSTRUCT
trial was funded by the NIHR Health Technology Assessment programme
(project no. 06/78/03). |
| Issue: |
1 |